Aurinia Pharmaceuticals (FRA:IKAP) Accumulated Depreciation : €-2.4 Mil (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Aurinia Pharmaceuticals Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Aurinia Pharmaceuticals's quarterly accumulated depreciation increased from Jun. 2024 (€-2.1 Mil) to Sep. 2024 (€-2.1 Mil) and increased from Sep. 2024 (€-2.1 Mil) to Dec. 2024 (€-2.4 Mil).

Aurinia Pharmaceuticals's annual accumulated depreciation increased from Dec. 2022 (€-1.4 Mil) to Dec. 2023 (€-1.8 Mil) and increased from Dec. 2023 (€-1.8 Mil) to Dec. 2024 (€-2.4 Mil).

Aurinia Pharmaceuticals Accumulated Depreciation Historical Data

The historical data trend for Aurinia Pharmaceuticals's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurinia Pharmaceuticals Accumulated Depreciation Chart

Aurinia Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

Get a 7-Day Free Trial

-0.15

-0.74

-1.37

-1.75

-2.42

Aurinia Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Accumulated Depreciation	Get a 7-Day Free Trial															-1.75	-1.90	-2.06	-2.14	-2.42

Aurinia Pharmaceuticals Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Aurinia Pharmaceuticals Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Aurinia Pharmaceuticals's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Aurinia Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aurinia Pharmaceuticals Inc (FRA:IKAP) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

AUPH:USA

Address

14315 - 118 Avenue, Suite 140, Edmonton, AB, CAN, T5L 4S6

Website

https://www.auriniapharma.com

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Aurinia Pharmaceuticals Headlines

No Headlines